#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    PIK3CA related overgrowth spectrum Familial amyotrophic lateral sclerosis Juvenile idiopathic arthritis Craniocerebral injury Plasma cell myeloma refractory Anaemia Laryngeal squamous cell carcinoma Rheumatoid arthritis Arteriosclerosis Hereditary neuropathic amyloidosis Acute lymphocytic leukaemia Plasma cell myeloma Congenital growth hormone deficiency Alveolar rhabdomyosarcoma Indolent systemic mastocytosis More trials…

    Learn about Rare Diseases

    Sarcoidosis Antisynthetase syndrome – Trials in Disease Medulloblastoma recurrent – Life with Disease Phenylketonuria – Diagnostics Erdheim-Chester disease – Basic Information Toxic epidermal necrolysis – Life with Disease Chordoma – Diagnostics Lymphangiosarcoma – Life with Disease Pelizaeus-Merzbacher disease – Diagnostics Pleomorphic leiomyosarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    NERANDOMILAST Naproxen Epirubicin RP3 Olive Oil, Refined Demeclocycline Hydrochloride Sevoflurane Cefotaxime Paroxetine Datopotamab Deruxtecan Nimorazole Relatlimab Telitacicept POTASSIUM HYDROXIDE Ibuprofen Resmetirom Abrocitinib Leuprorelin ALE.P02 Tng462 More therapies…

    Learn about Your Condition

    Glioblastoma Neurodermatitis Congenital pseudarthrosis Mixed dementia Becker's muscular dystrophy Brain cancer metastatic Muscular dystrophy Plasma cell leukaemia Short stature Adenocarcinoma gastric Complex regional pain syndrome Phaeochromocytoma Pulmonary sarcoidosis Lymphocytic leukaemia Oesophageal achalasia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Pulmonary arterial hypertension

  • Study of gallium-68 FAPI imaging to assess blood vessel changes in patients with pulmonary arterial hypertension receiving sotatercept

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Investigated Drugs:
    • Human Albumin As Macroaggregates
    • Sotatercept
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    France

  • Study of calcifediol treatment to improve vitamin D levels in adults with pulmonary arterial hypertension

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Investigated Drugs:
    • Alpha-Tocopherol
    • Calcifediol
    • TRIGLYCERIDES MEDIUM CHAIN
    Spain

  • Study of Empagliflozin to Improve Heart Function in Adults with Pulmonary Arterial Hypertension

    Not yet recruiting

    2 1
    Investigated Drugs:
    • Empagliflozin
    Germany

  • Study on Macitentan for Children with Pulmonary Arterial Hypertension

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Investigated Drugs:
    • Macitentan
    Hungary Poland Portugal Spain

  • Study on the Safety and Tolerability of Sotatercept for Patients with Pulmonary Arterial Hypertension

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Investigated Drugs:
    • Sotatercept
    Czechia France Hungary Italy The Netherlands Poland +1

  • Study on the Safety and Effects of PF-07868489 in Patients with Pulmonary Arterial Hypertension

    Not recruiting

    1 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Investigated Drugs:
    • PF-07868489
    Belgium Czechia France Germany Greece Italy +1
Previous Page
1 2 3 4 5 … 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!